Renal Cell Cancer, Recurrent Completed Phase 1 Trials for Bryostatin 1 (DB11752)

Also known as: Recurrent Renal Cell Cancer

IndicationStatusPhase
DBCOND0082537 (Renal Cell Cancer, Recurrent)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00112476Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment